Embecta Corp.

Embecta Corp. is a medical device manufacturer that focuses on diabetes management solutions. The company produces conventional and safety pen needles, insulin syringes, and safety injection devices designed for insulin and diabetes medication administration. These products feature protective mechanisms, such as automatic shields and sliding arms, to reduce accidental needlestick injuries for users and clinical personnel. Embecta supplies its diabetes injection devices to individual patients managing diabetes, healthcare professionals, hospitals, retail pharmacies, and other institutional healthcare networks.

Headquartered in Parsippany, New Jersey, Embecta maintains a global distribution network that reaches more than one hundred countries. An estimated thirty million individuals worldwide utilize its diabetes management products. The organization operates three manufacturing facilities situated in the United States, Ireland, and China. In addition, the business employs roughly 1,850 people globally, with approximately 700 employees based in the United States.

Summary of the business section of Embecta's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of September 30, 2025, we had approximately 1,850 regular employees globally, with approximately 700 employees in the United States.”